Horizon Therapeutics PLC (HZNP)
115.69
0.00 (0.00%)
USD |
NASDAQ |
Sep 29, 16:00
115.67
-0.02
(-0.02%)
After-Hours: 20:00
Horizon Therapeutics Cash from Investing (TTM): -142.87M for June 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -142.87M |
| March 31, 2023 | -135.03M |
| December 31, 2022 | -134.00M |
| September 30, 2022 | -121.77M |
| June 30, 2022 | -231.85M |
| March 31, 2022 | -305.34M |
| December 31, 2021 | -2.994B |
| September 30, 2021 | -3.023B |
| June 30, 2021 | -2.903B |
| March 31, 2021 | -2.975B |
| December 31, 2020 | -464.07M |
| September 30, 2020 | -411.17M |
| June 30, 2020 | -393.27M |
| March 31, 2020 | -234.21M |
| December 31, 2019 | -17.86M |
| September 30, 2019 | 25.78M |
| June 30, 2019 | 39.56M |
| March 31, 2019 | 38.47M |
| December 31, 2018 | 27.65M |
| September 30, 2018 | -1.868M |
| June 30, 2018 | -13.54M |
| March 31, 2018 | -113.43M |
| December 31, 2017 | -102.18M |
| September 30, 2017 | -935.99M |
| June 30, 2017 | -937.56M |
| Date | Value |
|---|---|
| March 31, 2017 | -848.81M |
| December 31, 2016 | -1.371B |
| September 30, 2016 | -499.29M |
| June 30, 2016 | -569.66M |
| March 31, 2016 | -1.517B |
| December 31, 2015 | -995.05M |
| September 30, 2015 | -1.081B |
| June 30, 2015 | -1.187B |
| March 31, 2015 | -228.66M |
| December 31, 2014 | -227.72M |
| September 30, 2014 | -216.55M |
| June 30, 2014 | -36.83M |
| March 31, 2014 | -36.40M |
| December 31, 2013 | -36.14M |
| September 30, 2013 | -0.967M |
| June 30, 2013 | -0.688M |
| March 31, 2013 | -1.478M |
| December 31, 2012 | -1.386M |
| September 30, 2012 | -2.517M |
| June 30, 2012 | -3.161M |
| March 31, 2012 | -2.246M |
| December 31, 2011 | -2.154M |
| September 30, 2011 | -0.884M |
| June 30, 2011 | -0.275M |
| March 31, 2011 | 5.54M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-3.023B
Minimum
Sep 2021
39.56M
Maximum
Jun 2019
-717.85M
Average
-187.36M
Median
Cash from Investing (TTM) Benchmarks
| Amgen Inc | -2.593B |
| Pfizer Inc | -27.21B |
| Perrigo Co PLC | -70.90M |
| Jazz Pharmaceuticals PLC | -410.34M |
| Iterum Therapeutics PLC | 29.68M |